Pelvic Floor Disorders Network Data Coordinating Center (U01)
盆底疾病网络数据协调中心 (U01)
基本信息
- 批准号:8699240
- 负责人:
- 金额:$ 388.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-08 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventBehavioralBiocompatible MaterialsBiometryCaringClinicalClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DesignCommunicationDataData AnalysesData CollectionData Coordinating CenterData FilesData QualityDevelopmentDiagnosisEnrollmentEnsureLeadershipMissionMonitorNational Institute of Child Health and Human DevelopmentNorth CarolinaObservational StudyOnline SystemsOperative Surgical ProceduresOutcomeOutcome MeasurePatient Outcomes AssessmentsPelvic Floor DisordersPelvic floor structurePreparationPreventionPrincipal InvestigatorProductivityProgram EvaluationProtocols documentationPublicationsQuality of lifeReportingResearchResearch DesignResearch PersonnelResolutionRunningSafetyServicesSiteSolutionsSpecimen HandlingSurveysSystemTimeUnited States National Institutes of HealthUniversitiesWomanclinical research sitecost effectivenessdata managementdesigndistributed dataexperienceflexibilityimprovedinnovationmeetingsmultidisciplinarytool
项目摘要
DESCRIPTION (provided by applicant): RTl proposes to serve as the data coordinating center (DCC) for the NICHD Pelvic Floor Disorders Network (PFDN), in support of its mission to improve the care of women with pelvic floor disorders (PFDs) by conducting well-designed, adequately powered studies of diagnosis, prevention, and treatment. We will draw upon our 35 years of experience as a DCC supporting multicenter NIH clinical research networks to provide the Network statistical leadership in study design and data analysis and operational support through data management and logistical services. Specifically, we will (1) collaborate in developing, implementing, and monitoring Network protocols; (2) provide data management, including preparation of public data files; (3) prepare data and safety reports for the Data Safety Monitoring Board and Network committees; (4) collaborate in the analysis of data and publication of results of Network studies; (5) coordinate acquisition of study materials and biological specimen processing; and (6) provide all other logistical support, including Network meetings and communication necessary to run an efficient and productive Network. This application has specific strengths that will enhance the scientific productivity of the PFDN: (1) Scientific leadership of Dr. Dennis Wallace, with more than 18 years experience as a senior clinical biostatistician and Principal Investigator for multisite NIH research networks. (2) Multidisciplinary experts, from RTl and The University of North Carolina, Chapel Hill (UNC), in biostatistics; surgical, behavioral, and quality of life outcomes; cost-effectiveness and program evaluation; and qualitative and quantitative surveys, who will collaborate with PFDN investigators to (a) develop innovative trial designs (conducting formative research for methodological advancements if needed) to address the unique problems in pelvic floor trials; (b) develop and implement new outcome measures; (c) leverage trial data with well-designed secondary observational studies that answer important ancillary questions; and (d) respond quickly to fluctuations in Network analytic needs. (3) A state-of-the art, flexible, and comprehensive web-based distributed data entry and management system that will (a) ensure high-quality data with rapid error resolution and real-time enrollment and adverse event monitoring; (b) provide creative solutions to difficult problems, like collecting patient-reported outcomes; and (c) provide site staff with study management and reporting tools that enhance the scientific quality and efficiency of clinical site trial activities.
RELEVANCE: The PFDN was established in 2001 to improve the care of women with PFDs by conducting well-designed, rigorous clinical trials and studies of diagnosis, prevention, and treatment. A DCC provides essential biostatistical and clinical trials expertise to such a productive multicenter research enterprise and ensures standardized study design and development, and data collection and analyses, using independent statistical expertise to formulate, design, monitor, and analyze RCTs and provides communications and logistical support between the disparate clinical sites to optimize the efficiency and productivity of the Network.
描述(由申请人提供):RTl拟担任NICHD盆底疾病网络(PFDN)的数据协调中心(DCC),以支持其使命,即通过开展设计良好、动力充足的诊断、预防和治疗研究来改善女性盆底疾病(PFDs)的护理。我们将利用我们作为DCC支持多中心NIH临床研究网络的35年经验,通过数据管理和后勤服务,在研究设计和数据分析以及运营支持方面为网络提供统计领导。具体而言,我们将(1)合作开发、实施和监测网络协议;(2)提供数据管理,包括准备公共数据文件;(3)为数据安全监测委员会和网络委员会准备数据和安全报告;(4)合作分析数据和发表网络研究结果;(5)协调研究材料的获取和生物标本的处理;(6)提供所有其他后勤支持,包括网络会议和运行高效和富有成效的网络所需的通信。该应用程序具有特定的优势,将提高PFDN的科学生产力:(1)Dennis Wallace博士的科学领导力,他作为多中心NIH研究网络的高级临床生物统计学家和主要研究者拥有超过18年的经验。(2)来自RTl和北卡罗来纳州大学(查佩尔山)的多学科专家,从事生物统计学;手术、行为和生活质量结局;成本效益和项目评估;以及定性和定量调查,他们将与PFDN的研究人员合作,(a)开发创新的试验设计(如有必要,进行形成性研究以促进方法学进步),以解决骨盆底试验中的独特问题;(B)制定和实施新的结局指标;(c)利用设计良好的二次观察性研究的试验数据,回答重要的辅助问题;(d)迅速应对网络分析需求的波动。(3)一个先进、灵活、全面的基于网络的分布式数据输入和管理系统,将(a)确保高质量的数据,快速解决错误,实时入组和不良事件监测;(B)为困难问题提供创造性的解决方案,如收集患者报告的结果;以及(c)为研究中心工作人员提供研究管理和报告工具,以提高临床研究中心试验活动的科学质量和效率。
相关性:PFDN成立于2001年,旨在通过进行精心设计的,严格的临床试验和诊断,预防和治疗研究来改善对PFDs妇女的护理。DCC为这样一个多中心研究企业提供必要的生物统计学和临床试验专业知识,并确保标准化的研究设计和开发,以及数据收集和分析,使用独立的统计学专业知识来制定,设计,监测和分析RCT,并在不同的临床研究中心之间提供通信和后勤支持,以优化网络的效率和生产力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIE G GANTZ其他文献
MARIE G GANTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIE G GANTZ', 18)}}的其他基金
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center
精准健康营养,由“我们所有人研究计划”提供支持:研究协调中心
- 批准号:
10874354 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center
精准健康营养,由“我们所有人研究计划”提供支持:研究协调中心
- 批准号:
10757488 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center
精准健康营养,由“我们所有人研究计划”提供支持:研究协调中心
- 批准号:
10382053 - 财政年份:2021
- 资助金额:
$ 388.39万 - 项目类别:
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center
精准健康营养,由“我们所有人研究计划”提供支持:研究协调中心
- 批准号:
10533365 - 财政年份:2021
- 资助金额:
$ 388.39万 - 项目类别:
Pelvic Floor Disorders Network Data Coordinating Center: (2016-2021)
盆底疾病网络数据协调中心:(2016-2021)
- 批准号:
10004349 - 财政年份:2019
- 资助金额:
$ 388.39万 - 项目类别:
Creating Public Use Datasets for PFDN Surgical Trials
为 PFDN 手术试验创建公共使用数据集
- 批准号:
9370095 - 财政年份:2017
- 资助金额:
$ 388.39万 - 项目类别:
Add-on: Bridge Funding for Pelvic Floor Disorder Network (PFDN)
附加项目:盆底疾病网络 (PFDN) 过渡资金
- 批准号:
10404758 - 财政年份:2011
- 资助金额:
$ 388.39万 - 项目类别:
Pelvic Floor Disorders Network Data Coordinating Center: Administrative Supplement: Noncontinuing Sites
盆底疾病网络数据协调中心:行政补充:非连续站点
- 批准号:
10751080 - 财政年份:2011
- 资助金额:
$ 388.39万 - 项目类别:
Pelvic Floor Disorders Network Data Coordinating Center
盆底疾病网络数据协调中心
- 批准号:
10533521 - 财政年份:2011
- 资助金额:
$ 388.39万 - 项目类别:
Pelvic Floor Disorders Network Data Coordinating Center: (2016-2021)
盆底疾病网络数据协调中心:(2016-2021)
- 批准号:
9980201 - 财政年份:2011
- 资助金额:
$ 388.39万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 388.39万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 388.39万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 388.39万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 388.39万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 388.39万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 388.39万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 388.39万 - 项目类别: